• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粪肠球菌万古霉素敏感型肠球菌菌血症,对万古霉素耐受菌株无反应,经高剂量达托霉素成功治疗。

E. faecalis vancomycin-sensitive enterococcal bacteremia unresponsive to a vancomycin tolerant strain successfully treated with high-dose daptomycin.

作者信息

Cunha Burke A, Mickail Nardeen, Eisenstein Lawrence

机构信息

Infectious Disease Division, Winthrop-University Hospital, Mineola, and the State University of New York School of Medicine, Stony Brook, New York, USA.

出版信息

Heart Lung. 2007 Nov-Dec;36(6):456-61. doi: 10.1016/j.hrtlng.2007.02.012.

DOI:10.1016/j.hrtlng.2007.02.012
PMID:18005808
Abstract

Enterococci are part of the normal flora of the gastrointestinal tract. Intra-abdominal and genitourinary enterococcal infections may be complicated by enterococcal bacteremia. Most strains of enterococci fecal flora in antibiotic-naive patients are E. faecalis. Because nearly all E. faecalis strains are sensitive to vancomycin, E. faecalis is synonymous with vancomycin-sensitive enterococci (VSE). E. faecium, which is nearly always vancomycin-resistant, is termed vancomycin-resistant enterococci (VRE). High-grade continuous enterococcal bacteremias may result in endocarditis. Persistent VSE and VRE bacteremias may be related to device-associated infections; intra-abdominal, pelvic, and/or renal abscesses; or enterococcal endocarditis. If these causes of persistent enterococcal bacteremia are eliminated, microbiologic and antimicrobial therapy-related causes for persistent bacteremia should be considered. We present a case of a male with a E. faecalis (VSE) bacteremia unresponsive to parenteral vancomycin therapy but sensitive to vancomycin in vitro (minimum inhibitory concentration [MIC] = 1 microg/mL). The patient was treated with high-dose daptomycin (12 mg/kg intravenously [IV] q 24 hours) empirically pending susceptibility testing. High-dose daptomycin therapy cleared the patient's E. faecalis bacteremia. Subsequently, it was determined that the strain of E. faecalis was "tolerant" of vancomycin (MIC = 1 microg/mL, MBC = >64 microg/mL). We believe this is the first case of enterococcal (VSE) bacteremia unresponsive to vancomycin tolerant strain of E. faecalis that responded to high-dose daptomycin (12 mg/kg IV q 24 hours) therapy.

摘要

肠球菌是胃肠道正常菌群的一部分。腹腔内和泌尿生殖道的肠球菌感染可能并发肠球菌菌血症。在未使用过抗生素的患者中,大多数肠道菌群中的肠球菌菌株为粪肠球菌。由于几乎所有粪肠球菌菌株对万古霉素敏感,粪肠球菌等同于万古霉素敏感肠球菌(VSE)。屎肠球菌几乎总是对万古霉素耐药,被称为万古霉素耐药肠球菌(VRE)。高度持续性肠球菌菌血症可能导致心内膜炎。持续性VSE和VRE菌血症可能与器械相关感染、腹腔内、盆腔和/或肾脓肿或肠球菌心内膜炎有关。如果消除了这些持续性肠球菌菌血症的病因,应考虑微生物学和抗菌治疗相关的持续性菌血症病因。我们报告一例男性粪肠球菌(VSE)菌血症患者,该患者对静脉注射万古霉素治疗无反应,但体外对万古霉素敏感(最低抑菌浓度[MIC]=1微克/毫升)。在等待药敏试验期间,该患者经验性地接受了高剂量达托霉素(12毫克/千克静脉注射[IV],每24小时一次)治疗。高剂量达托霉素治疗清除了患者的粪肠球菌菌血症。随后,确定该粪肠球菌菌株对万古霉素“耐受”(MIC=1微克/毫升,MBC>64微克/毫升)。我们认为这是首例对万古霉素耐药的粪肠球菌菌株引起的肠球菌(VSE)菌血症,该菌株对高剂量达托霉素(12毫克/千克静脉注射,每24小时一次)治疗有反应。

相似文献

1
E. faecalis vancomycin-sensitive enterococcal bacteremia unresponsive to a vancomycin tolerant strain successfully treated with high-dose daptomycin.粪肠球菌万古霉素敏感型肠球菌菌血症,对万古霉素耐受菌株无反应,经高剂量达托霉素成功治疗。
Heart Lung. 2007 Nov-Dec;36(6):456-61. doi: 10.1016/j.hrtlng.2007.02.012.
2
Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE).达托霉素治疗肠球菌血症:来自 Cubicin 结果登记与经验(CORE)研究的结果
Int J Antimicrob Agents. 2009 Jun;33(6):543-8. doi: 10.1016/j.ijantimicag.2008.12.007. Epub 2009 Feb 6.
3
Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.耐万古霉素肠球菌血症:粪肠球菌和屎肠球菌临床特征及结局的比较
J Microbiol Immunol Infect. 2008 Apr;41(2):124-9.
4
Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?万古霉素耐药肠球菌菌血症与达托霉素:是否需要更高剂量?
J Antimicrob Chemother. 2011 Sep;66(9):2112-8. doi: 10.1093/jac/dkr255. Epub 2011 Jun 22.
5
[Bacteremia caused by vancomycin-resistant Enterococcus faecalis. Report of 2 cases].[耐万古霉素粪肠球菌引起的菌血症。2例报告]
Enferm Infecc Microbiol Clin. 1991 Nov;9(9):547-50.
6
Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms.氨苄西林、万古霉素、利奈唑胺和庆大霉素对肠球菌生物膜活性的测定。
J Antimicrob Chemother. 2006 Apr;57(4):767-70. doi: 10.1093/jac/dkl013. Epub 2006 Feb 7.
7
[Vancomycin resistant enterococci in Austria].[奥地利的耐万古霉素肠球菌]
Wien Klin Wochenschr. 1997 May 9;109(9):312-20.
8
Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).亚太地区革兰氏阳性菌分离株的抗菌药敏性以及达托霉素、万古霉素和替考拉宁杀菌活性的体外评估:哨兵计划报告(2003 - 2004年)
Int J Antimicrob Agents. 2007 Aug;30(2):143-9. doi: 10.1016/j.ijantimicag.2007.03.015. Epub 2007 May 24.
9
Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).针对2005年在欧洲医疗中心分离出的耐甲氧西林葡萄球菌和耐万古霉素肠球菌测试达托霉素的抗菌活性。
BMC Infect Dis. 2007 Apr 18;7:29. doi: 10.1186/1471-2334-7-29.
10
[Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].[从尿液中分离出的肠球菌属的抗生素敏感性分析]
Przegl Lek. 2004;61(5):473-6.

引用本文的文献

1
Molecular detection of bacterial contamination in plasma using magnetic-based enrichment.使用基于磁珠的富集方法检测血浆中的细菌污染的分子检测。
Sci Rep. 2022 Jun 1;12(1):9151. doi: 10.1038/s41598-022-12960-5.
2
High-Level Antibiotic Tolerance of a Clinically Isolated Enterococcus faecalis Strain.一株临床分离粪肠球菌高水平抗生素耐受的研究
Appl Environ Microbiol. 2020 Dec 17;87(1). doi: 10.1128/AEM.02083-20.
3
Daptomycin for the treatment of major gram-positive infections after cardiac surgery.达托霉素用于治疗心脏手术后的主要革兰氏阳性菌感染。
J Cardiothorac Surg. 2016 Aug 4;11(1):120. doi: 10.1186/s13019-016-0519-7.
4
A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis.高剂量达托霉素治疗感染性心内膜炎有效性和安全性的多中心评估
J Antimicrob Chemother. 2013 Dec;68(12):2921-6. doi: 10.1093/jac/dkt294. Epub 2013 Aug 8.
5
β-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives.β-内酰胺类抗生素增加达托霉素对临床耐甲氧西林金黄色葡萄球菌菌株的抗菌活性,并防止达托霉素耐药衍生物的选择。
Antimicrob Agents Chemother. 2012 Dec;56(12):6192-200. doi: 10.1128/AAC.01525-12. Epub 2012 Sep 17.
6
Evaluation of standard- and high-dose daptomycin versus linezolid against vancomycin-resistant Enterococcus isolates in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.评估标准剂量和高剂量达托霉素与利奈唑胺对模拟心内膜赘生物的体外药代动力学/药效学模型中万古霉素耐药肠球菌分离株的作用。
Antimicrob Agents Chemother. 2012 Jun;56(6):3174-80. doi: 10.1128/AAC.06439-11. Epub 2012 Apr 2.
7
Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians.对临床医生而言,达托霉素中介粪肠球菌:一种新出现的挑战。
Clin Infect Dis. 2011 Jan 15;52(2):228-34. doi: 10.1093/cid/ciq113.
8
Observational study of the epidemiology and outcomes of vancomycin-resistant Enterococcus bacteraemia treated with newer antimicrobial agents.观察性研究新型抗菌药物治疗万古霉素耐药肠球菌菌血症的流行病学和结局。
Epidemiol Infect. 2011 Sep;139(9):1342-50. doi: 10.1017/S0950268810002475. Epub 2010 Nov 15.
9
A potential role for daptomycin in enterococcal infections: what is the evidence?达托霉素在肠球菌感染中的潜在作用:有何证据?
J Antimicrob Chemother. 2010 Jun;65(6):1126-36. doi: 10.1093/jac/dkq087. Epub 2010 Apr 2.